Study shows monoclonal antibody can lower common lung infection risk
New Delhi, June 5 (IANS) A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections in infants can halve hospitalisations for bronchiolitis, according to a study.